Press Information

For Immediate release                                                                       30 September 2008

ApaTech continues on FAST TRACK

ApaTech has been recognized for the second successive year as Britain’s fastest growing private medical technology company.

‘The Sunday Times Microsoft Tech Track 100’ awards announced on 28 September 2008 ranked ApaTech 5th in the top 100, up eight places on the Company’s position in last year’s awards. This recognises the tremendous sales performance of ApaTech over the three years to March 2008, which saw revenues grow at a compound annual growth rate of 205%.

ApaTech’s growth is based on the company’s unique development of silicate substituted calcium phosphate chemistry and novel manufacturing technologies, which provide a scaffold that mimics natural bone and stimulates rapid bone growth.

This significant advance is increasingly being adopted worldwide by orthopaedic and neuro-surgeons in spine fusion, joint reconstruction and trauma applications and the company is now selling its products in 21 countries.

Commenting on the award, Simon Cartmell, Chief Executive Officer of ApaTech said: “This is a great tribute to the success of our science and the dedication of our people; we are elated at achieving this award in two consecutive years.  We have taken some bold decisions in building the business and it is very rewarding when an independent organisation, such as Fast Track, endorses that boldness.”

Ends

Further Information:

ApaTech                                                                            +44 20 8731 4640

Simon Cartmell, CEO

simon.cartmell@apatech.com

www.apatech.com

Waughton                                                                                         +44 20 7796 9999

Robin Hepburn                                     

rhepburn@waughton.com   

www.waughton.com

Notes to Editors:

About ApaTech

ApaTech specialises in producing synthetic bone repair material. It has operations in London, England, Foxborough, USA, and Berlin, Germany, and is a world leader in bone graft technologies, selling its products in 21 countries around the world.

The Company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the Company’s leadership in applying the science of silicon to bone graft technologies. The Company believes that Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive and osteo-stimulatory activities.

ApaTech is backed by international investors, 3i and Healthcor and was recognized as Britain’s fastest growing medical technology company in both the 2008 and 2007 Sunday Times Fast Track 100 fastest growing private companies review.

More details can be found at www.apatech.com

About Tech Track 100 

The eight annual Tech Track 100 league table was published in The Sunday Times on 28 September 2008, with main sponsor PricewaterhouseCoopers and title sponsor Microsoft.

Tech Track 100 ranks Britain's fastest-growing private tech companies based on sales growth as measured by compound annual growth rate over three financial years. www.fasttrack.co.uk